Triethylenetetramine reduces some blood parameters in alloxan-induced diabetes mellitus in New Zealand white rabbit: evidence for histopathologic effects

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 45

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PBRE-2-4_005

تاریخ نمایه سازی: 10 دی 1402

Abstract:

This study aimed to assess whether the triethylenetetramine (TETA) is impressed the plasma level of homocysteine (Hcy), total sialic acid (TSA) and cardiac troponin I (cTnI) as cardiovascular diseases risk factors, cystatin c (Cys c) and glucose along with histopathologic changes in alloxan induced diabetes mellitus in rabbit. Twenty number New Zealand white rabbits were assigned for this study. After induction of diabetes mellitus, TETA was orally administrated with different doses (۱۰, ۲۰, ۴۰ mg/kg/day, A, B, C groups respectively) for ۶ months daily and group D (as positive control) not received TETA. In the following, above parameters, insulin and glucose were measured in the all groups. Furthermore, histopathologic evaluation was carried out for aorta, kidney and pancreas in the all ones. Amounts of plasma cTnI, Hcy, TSA, Cys c and glucose concentrations decreased significantly (P < ۰.۰۱) in group C (۴۰ mg/kg/day) compared with group D (positive control). In respect of insulin, normalizing of insulin occurred in group C (۴۰ mg/kg/day) compared with group D (positive control). It is worth mentioning that during increasing of TETA dose, those levels decreased. In terms of histopathology, ameliorative and restoring effect of TETA on pancreatic beta-cells, glomeruli, renal tubules and aorta was determined in this study. The results suggested that TETA administration plays substantial role in tremendous alleviation of forenamed parameters and amelioration of beta-cells, renal glomeruli and tubules. Hence, TETA in the dose ۴۰ mg/kg/day may utilize in the part of human diabetes mellitus management including cardiovascular, renal diseases and glucose normalizing.

Authors

Reza Golam Mohebbi

Graduate of Veterinary Medicine, Islamic Azad University, Urmia Branch, Urmia, Iran

Kaveh Azimzadeh

Department of Clinical Sciences, Veterinary Faculty, Urmia Branch, Islamic Azad University, Urmia, Iran

Amir Amniattalab

Department of Pathobiology, Veterinary Faculty, Urmia Branch, Islamic Azad University, Urmia, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ekin S, Mert N, Gunduz H, Meral I. Serum Sialic ...
  • Ugarte M, Brown M, Hollywood KA, Cooper GJ, Bishop PN, ...
  • Da Silva F, Williams RJ. The biological chemistry of the ...
  • Gong D, Lu J, Chen X, Reddy S, Crossman DJ, ...
  • Walter JY, Uriu-Hare KL, Olin KL, Oster MH, Anawalt BD, ...
  • Lu J, Gong D, Choong SY, Xu H, Chan YK, ...
  • Cho HY, Blum RA, Sunderland T, Cooper GJ, Jusko WJ. ...
  • Cooper GJ, Young AA, Gamble GD, Occleshaw CJ, Dissanayake AM, ...
  • Kojda G, Harrison D. Interactions between NO and reactive oxygen ...
  • Audelin MC, Genest J Jr. Homocysteine and cardiovascular disease in ...
  • Mansoor MA, Bergmark C, Haswell SJ, Savage IF, Evans PH, ...
  • Gopaul KP, Crook MA. Sialic acid: A novel marker of ...
  • Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, ...
  • Crook MA, Tutt P, Simpson H, Pickup JC. Serum sialic ...
  • Collinson PO, Gaze DC. Biomarkers of cardiovascular damage and dysfunction– ...
  • Saravanan G, Ponmurugan P, Sathiyavathi M, Vadivukkarasi S, Sengottuvelu S. ...
  • Al-Rasheed NM, Al-Rasheed Nawal M, Hasan IH, Al-Amin MA, Al-Ajmi ...
  • Villa P, Jiménez M, Soriano MC, Manzanares J, Casasnovas P. ...
  • Antognoni, MT, Siepi D, Porciello F, Rueca F, Fruganti G. ...
  • Lassus J, Harjola VP. Cystatin C: a step forward in ...
  • Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations ...
  • Ix JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, ...
  • Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of ...
  • coronary heart disease. data from the Heart and Soul Study. ...
  • Niccoli G, Conte M, Della Bona R, Altamura L, Siviglia ...
  • Puri D, Prabhu KM, Murthy PS. Mechanism of actions of ...
  • Sydow G. A simpllifield quick method for determination of sialic ...
  • Ryden L, Standl E, Bartnik M, Van den Berghe G, ...
  • Azimzadeh K, Nasiri Y, Farzadnia H, Mamash Sargaz T, Najafi ...
  • Uthus EO, Reeves PG, Saari JT. Copper deficiency decreases plasma ...
  • Tamura T, Hong KH, Mizuno Y, Johnston KE, Keen CL. ...
  • Cooper GJ. Therapeutic potential of copper chelation with triethylenetetramine in ...
  • Atabek ME, Pirgon O, Oran B, Erkul I, Kurtoglu S. ...
  • Rezaei A, Heidarian, E. Co-administration of trientine and flaxseed oil ...
  • Zhang L, Ward ML, Phillips AR, Zhang S, Kennedy J, ...
  • Liu X, Takeda N, Dhalla NS. Troponin I phosphorylation in ...
  • Rahman IU, Malik SA, Bashir M, Khan RU, Idrees M. ...
  • Gracheva EV, Samilova NN, Golovanova NK, Il'inskaya OP, Tararak EM, ...
  • Susztak K, Raff AC, Schiffer M, Böttinger EP. Glucose induced ...
  • نمایش کامل مراجع